BiotechTube
Home/SIGA Technologies/Daniel J. Luckshire
DJ

Daniel J. Luckshire

Chief Executive Officer

SIGA Technologies

Therapeutic Areas

Infectious DiseaseBiodefense

SIGA Technologies Pipeline

DrugIndicationPhase
TPOXX (tecovirimat) OralTreatment of SmallpoxApproved
TPOXX (tecovirimat) IVTreatment of SmallpoxApproved
TPOXX (tecovirimat)Treatment of Orthopoxvirus Infections (mpox, cowpox, vaccinia)Approved
Next-Generation Orthopoxvirus AntiviralsTreatment of Orthopoxvirus InfectionsDiscovery/Preclinical

Leadership Team at SIGA Technologies

DE
Dennis E. Hruby, Ph.D.
Chief Scientific Officer
D(
Dieter (DJ) Weinand
Chairman of the Board
View full SIGA Technologies profile